scispace - formally typeset
Open AccessJournal Article

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

Reads0
Chats0
TLDR
Since intensive glucose control with metformin appears to decrease the risk of diabetes-related endpoints in overweight diabetic patients, and is associated with less weight gain and fewer hypoglycaemic attacks than are insulin and sulphonylureas, it may be the first-line pharmacological therapy of choice in these patients.
About
This article is published in The Lancet.The article was published on 1998-09-12 and is currently open access. It has received 7395 citations till now. The article focuses on the topics: Metformin & Type 2 diabetes.

read more

Citations
More filters
Journal ArticleDOI

Advanced glycation end products and diabetic complications.

TL;DR: As more therapeutic agents are developed to inhibit AGE formation or limit their pathogenic influence during chronic diabetes, it is becoming clear that these anti-AGE strategies have an important role to play in the treatment of diabetic patients.
Journal ArticleDOI

Impaired Glucose Tolerance Increases Stroke Risk in Nondiabetic Patients With Transient Ischemic Attack or Minor Ischemic Stroke

TL;DR: A J-shaped relationship between baseline nonfasting glucose levels and stroke risk was found and impaired glucose tolerance is an independent risk factor for future stroke in nondiabetic patients with TIA or minor ischemic stroke.
Journal ArticleDOI

The maillard reaction in eye diseases.

TL;DR: This review evaluates the ever‐growing literature on AGEs in biological systems and draws relevant links to diseases such as diabetic retinopathy, age‐related macular degeneration, and cataract formation and outlines recent pharmaceutical strategies to inhibit Maillard reaction products.
Journal ArticleDOI

Changes in BMI and Weight Before and After the Development of Type 2 Diabetes

TL;DR: There was a progressive rise in weight, and after diagnosis, there was a tendency toward weight loss, and weight-loss interventions in individuals with diabetes will need to account for this tendency if they are to successfully modify the course of the disease.
References
More filters
Journal Article

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 - 
TL;DR: In this article, the effects of intensive blood-glucose control with either sulphonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes in a randomised controlled trial were compared.
Journal Article

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease

TL;DR: Sulfonylurea, metformin, and insulin therapies were similarly effective in improving glucose control compared with a policy of diet therapy and whether any specific therapy is advantageous or disadvantageous.
Journal ArticleDOI

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

TL;DR: The ability of troglitazone to reduce insulin resistance and improves glucose tolerance in obese subjects with either impaired or normal glucose tolerance could be useful in preventing NIDDM.
Journal ArticleDOI

Biguanides and NIDDM

TL;DR: Because metformin does not cause clinical hypoglycemia, it is actually an antihyperglycemic drug that helps combat hypertriglyceridemia, and it has been ascribed some vasoprotective properties.
Journal ArticleDOI

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

TL;DR: The UK Prospective Diabetes Study is a multi-centre, prospective, randomised, intervention trial of 5100 newly-diagnosed patients with Type 2 (non-insulin-dependent) diabetes mellitus which aims to determine whether improved blood glucose control will prevent complications and reduce the associated morbidity and mortality.
Related Papers (5)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 -